


The Fund aims to achieve above average capital growth.
| Name | % Net Assets |
|---|---|
| Roche Holding AG | 4.6% |
| EFG Eurobank Ergasias S.A. | 3.9% |
| Total S.A. | 3.3% |
| ASML Holding N.V. | 3.0% |
| AXA S.A. | 3.0% |
| UBS Ag | 2.9% |
| TrygVesta A/SV. | 2.8% |
| Carrefour S.A. | 2.7% |
| Nexans | 2.6% |
| Banco Bilbao Vizcaya Argentaria S.A. | 2.5% |
| Key | % Net Assets |
|---|---|
| 4.6% | |
| 3.9% | |
| 3.3% | |
| 3.0% | |
| 85.2% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 478.85p |
| Currency | GBP |
| Change | 0.71p |
| % | 0.15% |
| YTD change | 26.80p |
| YTD % | 5.93% |
| Fund Inception | 31/10/1986 |
|---|---|
| Fund Manager | Phil Cliff |
| TER | 1.68 (30-Mar-2012) |
| Minimum Investment | |
|---|---|
| Initial | £2000 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 3.75% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.08 |
You are here: research